Genomic Psychiatry cohort cohort
Evidence from:
primary |
all sources
Related entities (4)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| Genomic Psychiatry cohort | associated_with | bipolar disorder | — | 1 |
| Genomic Psychiatry cohort | associated_with | major depressive disorder | — | 1 |
| Genomic Psychiatry cohort | associated_with | schizoaffective disorder | — | 1 |
| Genomic Psychiatry cohort | associated_with | schizophrenia | — | 2 |
Mentioned in (5)
Papers in which this entity is mentioned.
- Associations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Cannabis-related Experiences in a Sample of Cannabis Users. (2023)
- Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. (2021)
- The association of polygenic risk for schizophrenia, bipolar disorder, and depression with neural connectivity in adolescents and young adults: examining developmental and sex differences. (2021)
- Gene Expression in Patient-Derived Neural Progenitors Implicates WNT5A Signaling in the Etiology of Schizophrenia. (2020)
- Comorbidity of severe psychotic disorders with measures of substance use. (2014)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| genomic psychiatry cohort | cohort | 5 | 5 |